Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens

@inproceedings{Marcelin2010PrevalenceOR,
  title={Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens},
  author={A. G. Marcelin and Charlotte Charpentier and Chrystophe Ferreira and Marc Wirden and Caroline Lemarchand and Diane Descamps and Vincent Calvez},
  year={2010}
}
Purpose of the study Fos-Amprenavir is one of the protease inhibitor that is recommended to treat protease inhibitor naïve of experienced patients. Amprenavir and darunavir share at least in part chemical structures and thus a possible selection of close protease gene mutations. Little is known about the frequency and the type of resistance mutations selected after virological failure to FosAmprenavir containing regimen. The aim of this study was to determine the genetic patterns and the… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…